Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15875041 | 0.77 | CASR (0.40) | CASRTSHRGAA | |
| SCHEMBL17352348 | 0.76 | ALDH1A1 (0.36) | CHRM3 | |
| SCHEMBL9112426 | 0.74 | TSHR (0.39) | CASRGABRA1GABRB2TSHRACHE | |
| SCHEMBL11138245 | 0.68 | TSHR (0.47) | CASRGABRA1GABRB2TSHRACHE | |
| SCHEMBL10437577 | 0.68 | ACHE (0.47) | CASRGABRA1GABRB2TSHRACHE | |
| SCHEMBL31589377 | 0.68 | TSHR (0.47) | CASRGABRA1GABRB2TSHRACHE | |
| SCHEMBL8785533 | 0.68 | TSHR (0.47) | CASRGABRA1GABRB2TSHRACHE | |
| SCHEMBL18883812 | 0.68 | GABRA1 (0.38) | CASRGABRA1GABRB2TSHRACHE | |
| SCHEMBL11082289 | 0.68 | ALDH1A1 (0.38) | CASRGABRA1GABRB2TSHRACHE | |
| SCHEMBL874172 | 0.66 | CASR (0.53) | CASRGABRA1GABRB2TSHRACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10160828-B2 | Group 8 transition metal catalysts and method for making same and process for use of same in metathesis reaction | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2018-12-25 | — | — | US | disclosed |
| US-10159966-B2 | Catalyst complexes with carbene ligand and method for making same and use in metathesis reaction | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2018-12-25 | — | — | US | disclosed |
| US-20170145152-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2017-05-25 | — | — | US | disclosed |
| US-20150367338-A1 | CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2015-12-24 | — | — | US | disclosed |
| US-20150367338-A1 | CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2015-12-24 | — | — | US | disclosed |
| US-20150367338-A1 | CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) (CN) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10159966-B2 | Catalyst complexes with carbene ligand and method for making same and use in metathesis reaction | MSMO1, ALOX12, SQLE | CASR 2202/4885GABRA1 1343/4885GABRB2 2199/4885 |
| US-20170145152-A1 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | F8, COASY, FADS1 | CASR 2930/4885GABRA1 1946/4885GABRB2 2554/4885 |
| US-20150367338-A1 | CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION | MSMO1, ALOX12, SQLE | CASR 2202/4885GABRA1 1343/4885GABRB2 2199/4885 |
| US-10160828-B2 | Group 8 transition metal catalysts and method for making same and process for use of same in metathesis reaction | F8, COASY, FADS1 | CASR 2930/4885GABRA1 1946/4885GABRB2 2554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.